Shareholding disclosure

Cristina Canepa

Declared position

6.79%

Threshold

Crossed upwards

Timeline

Published

17.02.2021

Transaction

09.02.2021

Voting rights breakdown

Voting rights acquired6.79%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL2F00053

Beneficial owner

Cristina Canepa

Declared address

Cristina Canepa, Milano

Reference is made to the disclosure dated 12 February 2021 regarding the termination of a group with Pierpaolo Cerani and Giovanni Cusmano.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Cristina Canepa

IGEA Pharma N.V.17.02.2021TAL2F00053

Disclosure summary

Cristina Canepa disclosed a holding in IGEA Pharma N.V. on the acquisition side, published by SIX Exchange Regulation on 17.02.2021, at 6.79% of voting rights. Notice category: Single shareholder.

Disclosed position

6.79%

Voting rights acquired

Voting rights acquired6.79%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Cristina Canepa disclosed a holding in IGEA Pharma N.V., published on 17.02.2021.

Publication date17.02.2021

Transaction date09.02.2021

Issuing companyIGEA Pharma N.V.

Beneficial ownerCristina Canepa

Declared addressCristina Canepa, Milano

CategorySingle shareholder

Voting rights acquired6.79%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAL2F00053

Conditions

Reference is made to the disclosure dated 12 February 2021 regarding the termination of a group with Pierpaolo Cerani and Giovanni Cusmano.

Source: SIX Exchange Regulation · Publication date: 17.02.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open